Bay City Capital
Bay City Capital LLC is a life sciences investment firm, founded in 1997, that manages general life sciences funds and strategic relationships to invest across stages from seed to public companies. The firm targets a diversified set of life-sciences sectors (biopharmaceuticals, drug discovery and research tools, medical devices, diagnostics, healthcare IT, nutrition/agribusiness) and combines financial, operational and scientific expertise with active board participation and syndication to support company building and liquidity outcomes.
Bay City Capital
San Francisco, California, United States, North America
Services
Board participation and governance support
Takes board seats (90% board representation based on invested capital) and works closely with management to guide company strategy and execution.
Executive recruitment and team building
Assists portfolio companies in recruiting and retaining key management and advisors.
Strategic partnering and business development
Identifies and helps establish strategic partnerships, including negotiating collaborations and encouraging strategic co-investor involvement.
Product development and execution support
Provides assistance with product development planning and execution leveraging scientific and operational expertise.
Syndication and capital mobilization
Acts as lead or co-lead investor (86% of invested capital) and coordinates syndication; historically each $1.00 from Bay City Capital attracted an additional $3.60 from co-investors.
Board participation and governance support
Takes board seats (90% board representation based on invested capital) and works closely with management to guide company strategy and execution.
Executive recruitment and team building
Assists portfolio companies in recruiting and retaining key management and advisors.
Strategic partnering and business development
Identifies and helps establish strategic partnerships, including negotiating collaborations and encouraging strategic co-investor involvement.
Product development and execution support
Provides assistance with product development planning and execution leveraging scientific and operational expertise.
Syndication and capital mobilization
Acts as lead or co-lead investor (86% of invested capital) and coordinates syndication; historically each $1.00 from Bay City Capital attracted an additional $3.60 from co-investors.
Portfolio
#Biopharmaceuticals
#Biopharmaceuticals
#Tools
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Tools
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals